↓ Skip to main content

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Overview of attention for article published in Journal of Hematology & Oncology, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
164 Dimensions

Readers on

mendeley
115 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Published in
Journal of Hematology & Oncology, March 2022
DOI 10.1186/s13045-022-01242-2
Pubmed ID
Authors

Mengling Wu, Qianrui Huang, Yao Xie, Xuyi Wu, Hongbo Ma, Yiwen Zhang, Yong Xia

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 115 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 10%
Student > Master 11 10%
Student > Bachelor 8 7%
Researcher 7 6%
Other 6 5%
Other 16 14%
Unknown 56 49%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 17%
Medicine and Dentistry 14 12%
Immunology and Microbiology 7 6%
Agricultural and Biological Sciences 5 4%
Unspecified 3 3%
Other 9 8%
Unknown 57 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2023.
All research outputs
#7,926,100
of 23,868,920 outputs
Outputs from Journal of Hematology & Oncology
#544
of 1,233 outputs
Outputs of similar age
#159,120
of 429,046 outputs
Outputs of similar age from Journal of Hematology & Oncology
#14
of 23 outputs
Altmetric has tracked 23,868,920 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,233 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,046 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.